3 results  1 of 1 

1 A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park
Cancer Res Treat.2017;49(3):706-716.   Published online 2016 October 18     DOI: http://dx.doi.org/10.4143/crt.2016.216
      
2 High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer
Isao Sakaguchi, Takeshi Motohara, Fumitaka Saito, Kiyomi Takaishi, Yukitoshi Fukumatsu, Toshimitsu Tohya, Saburo Shibata, Hiroyuki Mimori, Hironori Tashiro, Hidetaka Katabuchi
J Gynecol Oncol.2015;26(3):193-200.   Published online 2015 July 8     DOI: http://dx.doi.org/10.3802/jgo.2015.26.3.193
      
3 Oral Tegafur-uracil Plus Folinic Acid versus Intravenous 5-fluorouracil Plus Folinic Acid as Adjuvant Chemotherapy of Colon Cancer
Dong Joo Kim, Tae Il Kim, Jung Hoon Suh, Yong Suk Cho, Sung Kwan Shin, Jin Kyung Kang, Nam Kyu Kim, Won Ho Kim
Yonsei Med J.2003;44(4):665-675.   Published online 2009 March 30     DOI: http://dx.doi.org/10.3349/ymj.2003.44.4.665
      

 1 of 1